77 related articles for article (PubMed ID: 3265675)
1. The involvement of tumor necrosis factor-alpha (TNF-alpha) in immunomodulation and in septic shock.
Espevik T; Waage A
Dev Biol Stand; 1988; 69():139-42. PubMed ID: 3265675
[No Abstract] [Full Text] [Related]
2. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.
Grunfeld C; Palladino MA
Adv Intern Med; 1990; 35():45-71. PubMed ID: 2405602
[No Abstract] [Full Text] [Related]
3. First experience with immunomodulation in septic shock.
Josten C; Muhr G; Sistermann R
Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747
[No Abstract] [Full Text] [Related]
4. Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum.
Kumar A; Kumar A; Paladugu B; Mensing J; Parrillo JE
Crit Care Med; 2007 Feb; 35(2):358-64. PubMed ID: 17204997
[TBL] [Abstract][Full Text] [Related]
5. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.
Macchia D; Almerigogna F; Parronchi P; Ravina A; Maggi E; Romagnani S
Nature; 1993 Jun; 363(6428):464-6. PubMed ID: 7684824
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the peritoneal cell population of pregnant rabbits after LPS or TNF-alpha induced septic shock.
Terlikowski S; Sulkowska M; Południewski G; Dziecioł J; Sobaniec-Lotowska M; Musiatowicz B; Kulikowski M
Rocz Akad Med Bialymst; 1997; 42 Suppl 2():115-23. PubMed ID: 9646691
[TBL] [Abstract][Full Text] [Related]
7. [Levels of interleukin-2 )IL-2 and tumor necrosis factor alpha (TNF-alpha) mRNA in aged rat spleen under physiological conditions and in septic shock: possible role of pidotimod in gene expression modulation].
Arosio B; Santambrogio D; Gagliano N; Annoni G
Drugs Exp Clin Res; 1993; 19 Suppl():9-14. PubMed ID: 8625783
[No Abstract] [Full Text] [Related]
8. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.
Diao H; Kohanawa M
Infect Immun; 2005 Jun; 73(6):3745-8. PubMed ID: 15908405
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
Ranheim EA; Kipps TJ
Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines.
Abdelnour A; Tarkowski A
Cell Immunol; 1993 Apr; 147(2):279-93. PubMed ID: 8453672
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
Zhao X; Mohaupt M; Jiang J; Liu S; Li B; Qin Z
Cancer Res; 2007 May; 67(9):4443-50. PubMed ID: 17483359
[TBL] [Abstract][Full Text] [Related]
13. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells.
Motegi A; Kinoshita M; Sato K; Shinomiya N; Ono S; Nonoyama S; Hiraide H; Seki S
J Leukoc Biol; 2006 Mar; 79(3):463-72. PubMed ID: 16387840
[TBL] [Abstract][Full Text] [Related]
14. [T lymphocyte activation induced in vivo in different strains of mice after injection of anti-CD3 antibodies: prevention by an anti- TNF antibody].
Ferran C
Nephrologie; 1993; 14(1):23-4. PubMed ID: 8502345
[No Abstract] [Full Text] [Related]
15. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y
J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626
[TBL] [Abstract][Full Text] [Related]
16. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors.
Punzón C; Alcaide A; Fresno M
Int Immunopharmacol; 2003 Sep; 3(9):1293-9. PubMed ID: 12890427
[TBL] [Abstract][Full Text] [Related]
17. The role of APRIL and BAFF in lymphocyte activation.
Schneider P
Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
[TBL] [Abstract][Full Text] [Related]
18. T-cell-dependent shock induced by a bacterial superantigen.
Miethke T; Gaus H; Wahl C; Heeg K; Wagner H
Chem Immunol; 1992; 55():172-84. PubMed ID: 1418617
[No Abstract] [Full Text] [Related]
19. Treatment of septic shock with immunotherapy.
Smith AL
Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
[TBL] [Abstract][Full Text] [Related]
20. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.
Ye Q; Wang L; Wells AD; Tao R; Han R; Davidson A; Scott ML; Hancock WW
Eur J Immunol; 2004 Oct; 34(10):2750-9. PubMed ID: 15368291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
